{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:40Z","timestamp":1787025880693,"version":"build-2736575974"},"reference-count":34,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,9,6]]},"DOI":"10.3233\/jad-160347","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T10:32:00Z","timestamp":1471602720000},"page":"831-843","source":"Crossref","is-referenced-by-count":18,"title":["Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy"],"prefix":"10.1177","volume":"54","author":[{"given":"Ivana","family":"Zimova","sequence":"first","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Brezovakova","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Hromadka","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronela","family":"Weisova","sequence":"additional","affiliation":[{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Cubinkova","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Valachova","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Filipcik","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Jadhav","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Smolek","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Novak","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Zilka","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, AD Centre, Bratislava, Slovak Republic"},{"name":"Axon Neuroscience R&D Services SE, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160347_ref1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"15","author":"Reitz","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-160347_ref2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-160347_ref3","doi-asserted-by":"crossref","first-page":"20833","DOI":"10.1038\/srep20833","article-title":"Abnormal tau induces cognitive impairment through two different mechanisms: Synaptic dysfunction and neuronal loss","volume":"6","author":"Di","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-160347_ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt233","article-title":"Open questions for Alzheimer\u2018s disease immunotherapy","volume":"6","author":"Golde","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160347_ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12035-013-8440-8","article-title":"Protein truncation as a common denominator of human neurodegenerative foldopathies","volume":"48","author":"Jadhav","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160347_ref6","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","article-title":"Truncated tau from sporadic Alzheimer\u2018s disease suffices to drive neurofibrillary degenerationin vivo","volume":"580","author":"Zilka","year":"2006","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-160347_ref7","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.neurobiolaging.2010.10.015","article-title":"First transgenic rat model developing progressive cortical neurofibrillary tangles","volume":"33","author":"Filipcik","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160347_ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/alzrt277","article-title":"Identification of structural determinants on tau protein essential for its pathological function: Novel therapeutic target for tau immunotherapy in Alzheimer\u2019s disease","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160347_ref9","first-page":"1","article-title":"Silver staining of Alzheimer\u2019s neurofibrillary changes by means of physical development","volume":"19","author":"Gallyas","year":"1971","journal-title":"Acta Morphol Acad Hung"},{"key":"10.3233\/JAD-160347_ref10","first-page":"9","article-title":"Truncated tau deregulates synaptic markers in rat model for human tauopathy","volume":"23","author":"Jadhav","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-160347_ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2008.06.017","article-title":"Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effect of morphine and rofecoxib","volume":"174","author":"Moller","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-160347_ref12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3171\/2013.9.JNS13353","article-title":"Comprehensive analysis of neurobehavior associated with histomorphological alterations in a chronic constrictive nerve injury model through use of the CatWalk XT system","volume":"120","author":"Chiang","year":"2013","journal-title":"J Neurosurg"},{"key":"10.3233\/JAD-160347_ref13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/neu.2005.22.214","article-title":"The assessment of locomotor function in spinal cord injured rats: The importance of objective analysis of coordination","volume":"22","author":"Koopmans","year":"2005","journal-title":"J Neurotrauma"},{"key":"10.3233\/JAD-160347_ref14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-8-37","article-title":"Modeling Alzheimer\u2019s disease in transgenic rats","volume":"8","author":"Do Carmo","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-160347_ref15","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160347_ref16","doi-asserted-by":"crossref","first-page":"e26860","DOI":"10.1371\/journal.pone.0026860","article-title":"Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice","volume":"6","author":"Bi","year":"2011","journal-title":"PloS One"},{"key":"10.3233\/JAD-160347_ref17","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160347_ref18","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","article-title":"Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein","volume":"22","author":"Allen","year":"2002","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160347_ref19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/vaccines2030601","article-title":"Doubly phosphorylated peptide vaccines to protect transgenic P301S mice against Alzheimer\u2019s disease like tau aggregation","volume":"2","author":"Richter","year":"2014","journal-title":"Vaccines"},{"key":"10.3233\/JAD-160347_ref20","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive immunization with anti-Tau antibodies in two transgenic models: Reduction of Tau pathology and delay of disease progression","volume":"286","author":"Chai","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160347_ref21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","article-title":"Targeting phosphor-Ser422 by active tau immunotherapy in the THYTau22 mouse model: A suitable therapeutic approach","volume":"9","author":"Troquier","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-160347_ref22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","article-title":"Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies","volume":"122","author":"Dai","year":"2014","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-160347_ref23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2014.05.047","article-title":"p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice","volume":"575","author":"Walls","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160347_ref24","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","article-title":"Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2018s disease","volume":"137","author":"Collin","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-160347_ref25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-2008-15202","article-title":"Immunotherapy targeting pathological tau protein in Alzheimer\u2018s disease and related tauopathies","volume":"15","author":"Sigurdsson","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160347_ref26","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","article-title":"Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model","volume":"30","author":"Boutajangout","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160347_ref27","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1074\/jbc.M409876200","article-title":"Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R\/2N transgenic mice","volume":"280","author":"Terwel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160347_ref28","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","article-title":"Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)","volume":"25","author":"Ramsden","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160347_ref29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-160347_ref30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1471-4159.2002.01241.x","article-title":"Assembly of tau in transgenic animals expressing P301L tau: Alteration of phosphorylation and solubility","volume":"83","author":"Sahara","year":"2002","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160347_ref31","doi-asserted-by":"crossref","first-page":"e21050","DOI":"10.1371\/journal.pone.0021050","article-title":"P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating","volume":"6","author":"Takeuchi","year":"2005","journal-title":"PloS One"},{"key":"10.3233\/JAD-160347_ref32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: A user\u2019s guide","volume":"10","author":"Brook","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-160347_ref33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.02.081","article-title":"Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer\u2019s disease: Linkage of poorer cognitive performance to tau pathology in forebrain","volume":"1012","author":"Arendash","year":"2004","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160347_ref34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1460-9568.2008.06329.x","article-title":"Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load","volume":"28","author":"Koson","year":"2008","journal-title":"Eur J Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:46Z","timestamp":1777370626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160347"}},"subtitle":[],"editor":[{"given":"Alejandra","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":34,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-160347","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}